Hims & Hers Rallies 9% as Investors Bet Big on Peptide Pipeline and Novo Nordisk Deal
Hims & Hers (HIMS) shares surged on FDA peptide tailwinds and a Novo Nordisk partnership to distribute branded…
Hims & Hers Health (HIMS) Is Up 8.3% After Expanding Novo Nordisk GLP-1 Partnership And Launching New Weight-Loss Membership
In late March 2026, Hims & Hers Health, Inc. announced a renewed collaboration with Novo Nordisk to offer…
Novo Nordisk’s FDA-Approved GLP-1s Now Available With Hims & Hers
Starting today, eligible customers can access a broad assortment of treatment options, including the only FDA-approved GLP-1 weight…
Hims & Hers Health (HIMS) Valuation After Novo Nordisk Weight Loss Deal And Product Exit
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply…
Hims & Hers Faces Profitability Squeeze After Novo Nordisk Settlement
Hims & Hers resolves legal dispute with Novo Nordisk for weight-loss drug rights, but the shift to branded…
Does Hims & Hers (HIMS) Novo Nordisk Deal Quietly Redraw Its Risk Reward Profile?
Earlier in March 2026, Novo Nordisk agreed to resume selling its weight-loss drugs through the Hims & Hers…
Novo Nordisk Targets Obesity Edges With Irish Spend And Hims Alliance
Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…
Novo Nordisk Telehealth Deal With Hims And Hers Puts GLP-1 Pricing In Focus
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million…
Top 2 S&P 500 Stocks to Watch This Week After Hims & Hers Stock’s Surprise Move
Key Points Hims & Hers’ stock is up after ending its lawsuit with Novo Nordisk. The deal shows…
Novo Nordisk (NVO) Partners With Hims & Hers, Here’s What You Need to Know
Novo Nordisk A/S (NYSE:NVO) is one of the Most Undervalued Long Term Stocks to Buy According to Analysts.…
Why the Novo Nordisk and Hims & Hers Deal Is a Win for Both Stocks
To say that pharmaceutical giant Novo Nordisk (NYSE: NVO) has had a tumultuous relationship with telehealth company Hims…
Why the Novo Nordisk and Hims & Hers Deal Is a Win for Both Stocks
Key Points Novo Nordisk is dropping its lawsuit against Hims & Hers Health, as it has reached an…